Abbexa
Private Company
Total funding raised: $6.2M
Overview
Abbexa is a private, commercial-stage supplier of essential life science research reagents headquartered in Cambridge, UK. Operating as a B2B distributor and manufacturer, it offers a vast catalog of over 300,000 products, including antibodies, ELISA kits, and proteins, targeting academic and industrial research markets. The company generates revenue through direct sales and has established a significant online presence with distribution support in the US and UK. Its strategy focuses on providing a broad range of reliable and validated research tools to support biomedical discovery.
Technology Platform
Commercial and production infrastructure for biological reagents, including antibody development, immunoassay (ELISA/CLIA) kit production, protein/peptide synthesis, and custom multiplex assay services.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Abbexa competes in the crowded life science reagents market against giants like Abcam and Thermo Fisher Scientific, as well as numerous specialized smaller firms. Its strategy relies on offering a broad catalog, competitive pricing, and responsive service to differentiate itself, rather than competing on a single proprietary technology platform.